EP0810853B1
(de)
*
|
1995-02-24 |
2004-08-25 |
Elan Pharma International Limited |
Nanopartikel-dispersionen enthaltende aerosole
|
US6832735B2
(en)
*
|
2002-01-03 |
2004-12-21 |
Nanoproducts Corporation |
Post-processed nanoscale powders and method for such post-processing
|
US5993856A
(en)
*
|
1997-01-24 |
1999-11-30 |
Femmepharma |
Pharmaceutical preparations and methods for their administration
|
UA72189C2
(uk)
|
1997-11-17 |
2005-02-15 |
Янссен Фармацевтика Н.В. |
Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
|
US6000646A
(en)
*
|
1998-03-16 |
1999-12-14 |
Ranne; Bethyl H. |
Double barrel media mill for grinding and dispersing particulate matter and pigment for paint, coatings, ink and other fluid pigment vehicles
|
US20080213378A1
(en)
*
|
1998-10-01 |
2008-09-04 |
Elan Pharma International, Ltd. |
Nanoparticulate statin formulations and novel statin combinations
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
JP4613275B2
(ja)
*
|
1998-11-02 |
2011-01-12 |
エラン ファーマ インターナショナル,リミティド |
多粒子改質放出組成物
|
US20090297602A1
(en)
*
|
1998-11-02 |
2009-12-03 |
Devane John G |
Modified Release Loxoprofen Compositions
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
US6428814B1
(en)
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US6969529B2
(en)
|
2000-09-21 |
2005-11-29 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising copolymers of vinyl pyrrolidone and vinyl acetate as surface stabilizers
|
US6444223B1
(en)
|
1999-05-28 |
2002-09-03 |
Alkermes Controlled Therapeutics, Inc. |
Method of producing submicron particles of a labile agent and use thereof
|
EP1185371B2
(de)
*
|
1999-06-01 |
2008-11-12 |
Elan Pharma International Limited |
Kleinmühle und verfahren dafür
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US6656504B1
(en)
|
1999-09-09 |
2003-12-02 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
|
ATE453454T1
(de)
|
2000-04-26 |
2010-01-15 |
Elan Pharma Int Ltd |
Vorrichtung zur sanitären nassvermahlung
|
AU2001259671B2
(en)
|
2000-05-10 |
2004-06-24 |
Rtp Pharma Inc. |
Media milling
|
US6316029B1
(en)
|
2000-05-18 |
2001-11-13 |
Flak Pharma International, Ltd. |
Rapidly disintegrating solid oral dosage form
|
CA2420597C
(en)
|
2000-08-31 |
2011-05-17 |
Rtp Pharma Inc. |
Milled particles
|
US20080241070A1
(en)
*
|
2000-09-21 |
2008-10-02 |
Elan Pharma International Ltd. |
Fenofibrate dosage forms
|
US7998507B2
(en)
*
|
2000-09-21 |
2011-08-16 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of mitogen-activated protein (MAP) kinase inhibitors
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
US7276249B2
(en)
*
|
2002-05-24 |
2007-10-02 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
US20030224058A1
(en)
*
|
2002-05-24 |
2003-12-04 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
RS51449B
(sr)
*
|
2001-01-26 |
2011-04-30 |
Schering Corporation |
Kombinacija aktivatora peroksizom proliferator-aktiviranog receptora (ppar) i inhibitora apsorpcije sterola i lečenje vaskularnih indikacija
|
US20060287254A1
(en)
*
|
2001-01-26 |
2006-12-21 |
Schering Corporation |
Use of substituted azetidinone compounds for the treatment of sitosterolemia
|
US7100851B2
(en)
*
|
2001-04-27 |
2006-09-05 |
Kansai Paint Co., Ltd. |
Method and apparatus for dispersing pigment in liquid medium
|
US6976647B2
(en)
*
|
2001-06-05 |
2005-12-20 |
Elan Pharma International, Limited |
System and method for milling materials
|
ATE291899T1
(de)
*
|
2001-06-22 |
2005-04-15 |
Marie Lindner |
Screening-verfahren mit hohem durchsatz (hts) unter verwendung von labormühlen oder microfluidics
|
US7758890B2
(en)
|
2001-06-23 |
2010-07-20 |
Lyotropic Therapeutics, Inc. |
Treatment using dantrolene
|
US8403367B2
(en)
|
2001-08-02 |
2013-03-26 |
Eastman Kodak Company |
Authentication using near-field optical imaging
|
US6722699B2
(en)
|
2001-08-02 |
2004-04-20 |
Eastman Kodak Company |
Authentication using near-field optical imaging
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
DK1429731T3
(da)
*
|
2001-09-19 |
2007-05-14 |
Elan Pharma Int Ltd |
Nanopartikelformuleringer indeholdende insulin
|
ATE345793T1
(de)
*
|
2001-09-21 |
2006-12-15 |
Schering Corp |
Behandlung von xanthom mittels azetidinon- derivate als hemmer der sterol absorption
|
US7053080B2
(en)
*
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
JP2005508939A
(ja)
*
|
2001-10-12 |
2005-04-07 |
エラン ファーマ インターナショナル,リミティド |
即時放出および徐放特性を組み合わせて有する組成物
|
EP1450863A4
(de)
*
|
2001-11-07 |
2009-01-07 |
Imcor Pharmaceutical Company |
Verfahren für die bilddarstellung von gefässen mit nanoteilchenförmigen kontrastmitteln
|
CA2471400A1
(en)
|
2001-12-20 |
2003-07-03 |
Femmepharma, Inc. |
Vaginal delivery of drugs
|
US20030129242A1
(en)
*
|
2002-01-04 |
2003-07-10 |
Bosch H. William |
Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
|
ATE464880T1
(de)
*
|
2002-02-04 |
2010-05-15 |
Elan Pharma Int Ltd |
Arzneistoffnanopartikel mit lysozym- oberflächenstabilisator
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
US6699963B2
(en)
|
2002-03-18 |
2004-03-02 |
The Procter & Gamble Company |
Grinding process for plastic material and compositions therefrom
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
CA2479735C
(en)
*
|
2002-03-20 |
2011-05-17 |
Elan Pharma International Ltd. |
Fast dissolving dosage forms having reduced friability
|
CA2479665C
(en)
*
|
2002-03-20 |
2011-08-30 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
WO2003082213A2
(en)
*
|
2002-03-28 |
2003-10-09 |
Imcor Pharmaceutical Company |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
US20040105889A1
(en)
*
|
2002-12-03 |
2004-06-03 |
Elan Pharma International Limited |
Low viscosity liquid dosage forms
|
US7101576B2
(en)
*
|
2002-04-12 |
2006-09-05 |
Elan Pharma International Limited |
Nanoparticulate megestrol formulations
|
EP2263650A3
(de)
|
2002-04-12 |
2013-12-25 |
Alkermes Pharma Ireland Limited |
Nanopartikuläre Megestrol- Formulierungen
|
US20100226989A1
(en)
*
|
2002-04-12 |
2010-09-09 |
Elan Pharma International, Limited |
Nanoparticulate megestrol formulations
|
US9101540B2
(en)
|
2002-04-12 |
2015-08-11 |
Alkermes Pharma Ireland Limited |
Nanoparticulate megestrol formulations
|
DE10218109A1
(de)
*
|
2002-04-23 |
2003-11-20 |
Jenapharm Gmbh |
Verfahren zum Herstellen von Kristallen, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
|
DE10218107A1
(de)
*
|
2002-04-23 |
2003-11-20 |
Jenapharm Gmbh |
Verfahren zum Herstellen von Kristallen von Steroiden, danach erhältliche Kristalle und deren Verwendung in pharmazeutischen Formulierungen
|
US20070264348A1
(en)
*
|
2002-05-24 |
2007-11-15 |
Elan Pharma International, Ltd. |
Nanoparticulate fibrate formulations
|
WO2003103632A1
(en)
*
|
2002-06-10 |
2003-12-18 |
Elan Pharma International, Ltd. |
Nanoparticulate polycosanol formulations and novel polycosanol combinations
|
US20040258757A1
(en)
*
|
2002-07-16 |
2004-12-23 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
US7713551B2
(en)
|
2002-09-11 |
2010-05-11 |
Elan Pharma International Ltd. |
Gel stabilized nanoparticulate active agent compositions
|
EP1624958A2
(de)
*
|
2002-10-09 |
2006-02-15 |
Novozymes A/S |
Verfahren zur verbesserung von partikelzusammensetzungen
|
WO2004043440A1
(en)
*
|
2002-11-12 |
2004-05-27 |
Elan Pharma International Ltd. |
Fast-disintegrating solid dosage forms being not friable and comprising pullulan
|
US20050095267A1
(en)
*
|
2002-12-04 |
2005-05-05 |
Todd Campbell |
Nanoparticle-based controlled release polymer coatings for medical implants
|
WO2004058216A2
(en)
*
|
2002-12-17 |
2004-07-15 |
Elan Pharma International Ltd. |
Milling microgram quantities of nanoparticulate candidate compounds
|
WO2004060322A2
(en)
|
2003-01-02 |
2004-07-22 |
Femmepharma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
US9173836B2
(en)
|
2003-01-02 |
2015-11-03 |
FemmeParma Holding Company, Inc. |
Pharmaceutical preparations for treatments of diseases and disorders of the breast
|
EP1587499A1
(de)
*
|
2003-01-31 |
2005-10-26 |
Elan Pharma International Limited |
Nanopartikuläre topiramat formulierung
|
US20040208833A1
(en)
*
|
2003-02-04 |
2004-10-21 |
Elan Pharma International Ltd. |
Novel fluticasone formulations
|
US8512727B2
(en)
|
2003-03-03 |
2013-08-20 |
Alkermes Pharma Ireland Limited |
Nanoparticulate meloxicam formulations
|
US20100297252A1
(en)
|
2003-03-03 |
2010-11-25 |
Elan Pharma International Ltd. |
Nanoparticulate meloxicam formulations
|
JP2007515361A
(ja)
*
|
2003-03-06 |
2007-06-14 |
レンセラー・ポリテクニック・インスティチュート |
ナノ粒子の、室温におけるバルク固体からの迅速な生成
|
ATE418551T1
(de)
*
|
2003-03-07 |
2009-01-15 |
Schering Corp |
Substituierte azetidinon-derivate, deren pharmazeutische formulierungen und deren verwendung zur behandlung von hypercholesterolemia
|
US7235543B2
(en)
*
|
2003-03-07 |
2007-06-26 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
US7459442B2
(en)
*
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
CA2523035C
(en)
*
|
2003-05-22 |
2011-04-26 |
Elan Pharma International Ltd. |
Sterilization of dispersions of nanoparticulate active agents with gamma radiation
|
CA2534924A1
(en)
*
|
2003-08-08 |
2005-02-24 |
Elan Pharma International Ltd. |
Novel metaxalone compositions
|
US7618181B2
(en)
*
|
2003-10-23 |
2009-11-17 |
Kansai Paint Co., Ltd. |
Method for dispersing pigment in liquid medium
|
US7879360B2
(en)
*
|
2003-11-05 |
2011-02-01 |
Elan Pharma International, Ltd. |
Nanoparticulate compositions having a peptide as a surface stabilizer
|
EP1559419A1
(de)
*
|
2004-01-23 |
2005-08-03 |
Fournier Laboratories Ireland Limited |
Pharmazeutische Darreichungsformen enthaltend Metformin und ein Fibrat, sowie deren Herstellungsprozesse
|
EP1621200A1
(de)
*
|
2004-07-26 |
2006-02-01 |
Fournier Laboratories Ireland Limited |
Pharmazeutische Kombinationen enthaltend einen Hemmstoff der Plättchenaggregation und ein Fibrat
|
EP2623095A1
(de)
|
2004-11-16 |
2013-08-07 |
Elan Pharma International Limited |
Injizierbare Olanzapin-Formulierungen in Nanoteilchenform
|
UA89513C2
(uk)
*
|
2004-12-03 |
2010-02-10 |
Элан Фарма Интернешнл Лтд. |
Стабільна композиція з наночастинок ралоксифену гідрохлориду
|
CA2590675A1
(en)
*
|
2004-12-15 |
2006-06-22 |
Elan Pharma International Ltd. |
Nanoparticulate tacrolimus formulations
|
WO2006069098A1
(en)
*
|
2004-12-22 |
2006-06-29 |
Elan Pharma International Ltd. |
Nanoparticulate bicalutamide formulations
|
CN101107021A
(zh)
*
|
2004-12-30 |
2008-01-16 |
金文申有限公司 |
包含信号提供试剂、植入物材料和药物的组合
|
BRPI0518101A
(pt)
*
|
2004-12-31 |
2008-10-28 |
Iceutica Pty Ltd |
métodos de produção e sìntese de composições nanoparticuladas, composições obtidas e seu uso
|
WO2006074218A2
(en)
*
|
2005-01-06 |
2006-07-13 |
Elan Pharma International Ltd. |
Nanoparticulate candesartan formulations
|
JP2008527119A
(ja)
*
|
2005-01-13 |
2008-07-24 |
シンベンション アーゲー |
炭素ナノ粒子を含有する複合材料
|
BRPI0606486A2
(pt)
*
|
2005-01-24 |
2009-06-30 |
Cinv Ag |
materiais compósitos contendo metal
|
US20060198896A1
(en)
|
2005-02-15 |
2006-09-07 |
Elan Pharma International Limited |
Aerosol and injectable formulations of nanoparticulate benzodiazepine
|
EP1855651A4
(de)
*
|
2005-03-03 |
2011-06-15 |
Elan Pharma Int Ltd |
Nanopartikelzusammensetzungen heterocyclischer amidderivate
|
US20060204588A1
(en)
*
|
2005-03-10 |
2006-09-14 |
Elan Pharma International Limited |
Formulations of a nanoparticulate finasteride, dutasteride or tamsulosin hydrochloride, and mixtures thereof
|
NZ561666A
(en)
*
|
2005-03-17 |
2010-05-28 |
Elan Pharma Int Ltd |
Nanoparticulate biphosphonate compositions
|
CN101142149A
(zh)
*
|
2005-03-18 |
2008-03-12 |
金文申有限公司 |
制备多孔烧结金属材料的方法
|
BRPI0609700A2
(pt)
*
|
2005-03-23 |
2010-04-20 |
Elan Pharma Int Ltd |
formulações de corticosteróide nanoparticulado e antihistamina
|
MX2007012778A
(es)
*
|
2005-04-12 |
2008-01-11 |
Elan Pharma Int Ltd |
Formulaciones de derivados de quinazolina nanoparticuladas.
|
US7825087B2
(en)
|
2005-04-12 |
2010-11-02 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising cyclosporine
|
US20060246141A1
(en)
*
|
2005-04-12 |
2006-11-02 |
Elan Pharma International, Limited |
Nanoparticulate lipase inhibitor formulations
|
JP2008540546A
(ja)
*
|
2005-05-10 |
2008-11-20 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子クロピドグレル製剤
|
WO2006132752A1
(en)
*
|
2005-05-10 |
2006-12-14 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising vitamin k2
|
JP2008540691A
(ja)
*
|
2005-05-16 |
2008-11-20 |
エラン・ファルマ・インターナショナル・リミテッド |
セファロスポリンを含むナノ粒子および放出制御組成物
|
US20100028439A1
(en)
*
|
2005-05-23 |
2010-02-04 |
Elan Pharma International Limited |
Nanoparticulate stabilized anti-hypertensive compositions
|
US20070042049A1
(en)
*
|
2005-06-03 |
2007-02-22 |
Elan Pharma International, Limited |
Nanoparticulate benidipine compositions
|
WO2007053197A2
(en)
*
|
2005-06-03 |
2007-05-10 |
Elan Pharma International, Limited |
Nanoparticulate acetaminophen formulations
|
US20060275372A1
(en)
|
2005-06-03 |
2006-12-07 |
Elan Pharma International Limited |
Nanoparticulate imatinib mesylate formulations
|
DE112006001606T5
(de)
|
2005-06-08 |
2009-07-09 |
Elan Pharma International Ltd., Athlone |
Nanopartikuläre und eine kontrollierte Freisetzung aufweisende Zusammensetzung, die Cefditoren umfassen
|
ATE446742T1
(de)
*
|
2005-06-09 |
2009-11-15 |
Elan Pharma Int Ltd |
Nanopartikuläre ebastinformulierungen
|
KR20080016952A
(ko)
*
|
2005-06-13 |
2008-02-22 |
엘란 파마 인터내셔널 리미티드 |
나노입자형 클로피도그렐과 아스피린의 배합 제제
|
CA2612384A1
(en)
*
|
2005-06-15 |
2006-12-28 |
Elan Pharma International, Limited |
Nanoparticulate azelnidipine formulations
|
AU2006265196A1
(en)
*
|
2005-07-01 |
2007-01-11 |
Cinvention Ag |
Medical devices comprising a reticulated composite material
|
EP1902087A1
(de)
*
|
2005-07-01 |
2008-03-26 |
Cinvention Ag |
Verfahren zur herstellung von porösen retikulierten verbundwerkstoffen
|
EP1904041A2
(de)
*
|
2005-07-07 |
2008-04-02 |
Elan Pharma International Limited |
Nanopartikuläre clarithromycinformulierung
|
GB0516549D0
(en)
*
|
2005-08-12 |
2005-09-21 |
Sulaiman Brian |
Milling system
|
WO2007033239A2
(en)
*
|
2005-09-13 |
2007-03-22 |
Elan Pharma International, Limited |
Nanoparticulate tadalafil formulations
|
EP2279727A3
(de)
|
2005-09-15 |
2011-10-05 |
Elan Pharma International Limited |
Nanoteilchenförmige Aripiprazolformulierungen
|
KR20080063408A
(ko)
*
|
2005-10-18 |
2008-07-03 |
신벤션 아게 |
열경화성 수지 입자 및 이의 제조 방법
|
US8022054B2
(en)
|
2005-11-28 |
2011-09-20 |
Marinus Pharmaceuticals |
Liquid ganaxolone formulations and methods for the making and use thereof
|
UA96936C2
(uk)
|
2005-12-29 |
2011-12-26 |
Лексикон Фармасьютикалз, Инк. |
Поліциклічні похідні амінокислот і їх застосування
|
US7649098B2
(en)
|
2006-02-24 |
2010-01-19 |
Lexicon Pharmaceuticals, Inc. |
Imidazole-based compounds, compositions comprising them and methods of their use
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
US10137083B2
(en)
|
2006-03-07 |
2018-11-27 |
SGN Nanopharma Inc |
Ophthalmic preparations
|
US11311477B2
(en)
|
2006-03-07 |
2022-04-26 |
Sgn Nanopharma Inc. |
Ophthalmic preparations
|
CA2645080A1
(en)
*
|
2006-03-07 |
2007-09-13 |
Novavax,Inc. |
Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
|
BRPI0712130A2
(pt)
*
|
2006-05-30 |
2012-01-17 |
Elan Pharma Int Ltd |
formulações de posaconazol em nanopartìculas
|
AU2007264418B2
(en)
|
2006-06-30 |
2012-05-03 |
Iceutica Pty Ltd |
Methods for the preparation of biologically active compounds in nanoparticulate form
|
TW200820991A
(en)
*
|
2006-07-10 |
2008-05-16 |
Elan Pharma Int Ltd |
Nanoparticulate sorafenib formulations
|
KR20090031618A
(ko)
*
|
2006-07-12 |
2009-03-26 |
엘란 코포레이션, 피엘씨 |
나노입자형 모다피닐 제제
|
EP2101735A2
(de)
*
|
2006-11-28 |
2009-09-23 |
Marinus Pharmaceuticals, Inc. |
Nanoteilchenförmige formulierungen und verfahren zur herstellung und verwendung
|
UA99270C2
(en)
|
2006-12-12 |
2012-08-10 |
Лексикон Фармасьютикалз, Инк. |
4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use
|
CN101646402A
(zh)
*
|
2007-01-19 |
2010-02-10 |
金文申有限公司 |
用粉末模塑法制成的多孔、不可降解植入物
|
EP2129768A2
(de)
*
|
2007-02-28 |
2009-12-09 |
Cinvention Ag |
Grossflächiges kultivierungssystem mit oberflächenvergrösserndem substrat
|
WO2008104599A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Cinvention Ag |
High surface cultivation system bag
|
WO2008104587A2
(en)
*
|
2007-02-28 |
2008-09-04 |
Cinvention Ag |
High surface cultivation system with filler
|
EP2126040A1
(de)
*
|
2007-02-28 |
2009-12-02 |
Cinvention Ag |
Kultivierungssystem mit grosser oberfläche
|
JP2011520779A
(ja)
*
|
2008-03-21 |
2011-07-21 |
エラン・ファルマ・インターナショナル・リミテッド |
イマチニブの部位特異的送達のための組成物および使用の方法
|
WO2010096558A1
(en)
|
2009-02-18 |
2010-08-26 |
Eyeon Particle Sciences Llc |
Bi-functional co-polymer use for ophthalmic and other topical and local applications
|
EP3045043B1
(de)
|
2009-02-26 |
2020-04-29 |
Relmada Therapeutics, Inc. |
Oral einnehmbare pharmazeutische zusammensetzungen aus 3-hydroxy-n-methylmorphinan mit verzögerter freisetzung und verwendungsverfahren dafür
|
FR2945950A1
(fr)
|
2009-05-27 |
2010-12-03 |
Elan Pharma Int Ltd |
Compositions de nanoparticules anticancereuses et procedes pour les preparer
|
JP6072539B2
(ja)
|
2009-05-27 |
2017-02-01 |
アルカーメス ファーマ アイルランド リミテッド |
ナノ粒子活性物質組成物におけるフレーク状凝集の軽減
|
CN102480958B
(zh)
|
2009-06-12 |
2015-08-19 |
Cynapsus疗法有限公司 |
舌下阿扑吗啡
|
HUP0900376A2
(en)
|
2009-06-19 |
2011-01-28 |
Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag |
Nanoparticulate candesartan cilexetil composition
|
HUP0900384A2
(en)
|
2009-06-19 |
2011-01-28 |
Nangenex Nanotechnologiai Zartkoerueen Muekoedoe Reszvenytarsasag |
Nanoparticulate olmesartan medoxomil compositions
|
US20120128740A1
(en)
|
2009-06-19 |
2012-05-24 |
Filipcsei Genoveva |
Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them
|
RU2526914C2
(ru)
|
2009-06-19 |
2014-08-27 |
Наноформ Хунгари Лтд. |
Композиции телмисартана в форме наночастиц и способ их получения
|
JP2013510092A
(ja)
|
2009-11-05 |
2013-03-21 |
レクシコン ファーマシューティカルズ インコーポレイテッド |
がんの治療のためのトリプトファンヒドロキシラーゼ阻害剤
|
WO2011100285A1
(en)
|
2010-02-10 |
2011-08-18 |
Lexicon Pharmaceuticals, Inc. |
Tryptophan hydroxylase inhibitors for the treatment of metastatic bone disease
|
ES2689520T3
(es)
|
2010-04-23 |
2018-11-14 |
Kempharm, Inc. |
Formulación terapéutica para reducir los efectos secundarios de fármacos
|
WO2011146583A2
(en)
|
2010-05-19 |
2011-11-24 |
Elan Pharma International Limited |
Nanoparticulate cinacalcet formulations
|
HUP1000299A2
(hu)
|
2010-06-08 |
2012-02-28 |
Nanoform Cardiovascular Therapeutics Ltd |
Nanostrukturált Atorvastatint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás elõállításukra
|
HUP1000325A2
(en)
|
2010-06-18 |
2012-01-30 |
Druggability Technologies Ip Holdco Jersey Ltd |
Nanostructured aprepitant compositions and process for their preparation
|
HUP1000327A2
(en)
|
2010-06-18 |
2012-01-30 |
Druggability Technologies Ip Holdco Jersey Ltd |
Composition containing nanostructured ezetibime and process for it's preparation
|
AU2011305566A1
(en)
|
2010-09-22 |
2013-05-02 |
Map Pharmaceuticals, Inc. |
Aerosol composition for administering drugs
|
DE102010052656A1
(de)
*
|
2010-11-26 |
2012-05-31 |
Netzsch-Feinmahltechnik Gmbh |
Hydraulische Mahlkugel Zu- und Abfuhr für Rührwerkskugelmühlen
|
CA2821756C
(en)
|
2010-12-16 |
2021-06-29 |
Cynapsus Therapeutics, Inc. |
Sublingual films comprising apomorphine and an organic base
|
WO2013059676A1
(en)
|
2011-10-21 |
2013-04-25 |
Subhash Desai |
Compositions for reduction of side effects
|
EP2780009A4
(de)
|
2011-11-17 |
2015-05-06 |
Univ Colorado Regents |
Verfahren und zusammensetzungen zur verbesserten wirkstofffreisetzung ins auge und formulierungen mit verlängerter freisetzung
|
CN107875127A
(zh)
*
|
2012-02-28 |
2018-04-06 |
艾塞尤提卡控股公司 |
可吸入药物组合物
|
US20130303763A1
(en)
|
2012-03-30 |
2013-11-14 |
Michael D. Gershon |
Methods and compositions for the treatment of necrotizing enterocolitis
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
CA2871778C
(en)
|
2012-05-03 |
2022-09-13 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
EP2844227B1
(de)
|
2012-05-03 |
2020-11-18 |
Kala Pharmaceuticals, Inc. |
Pharmazeutische nanopartikel mit verbessertem mukosalem transport
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
WO2014127214A1
(en)
|
2013-02-15 |
2014-08-21 |
Kala Pharmaceuticals, Inc. |
Therapeutic compounds and uses thereof
|
JP2016510000A
(ja)
|
2013-02-20 |
2016-04-04 |
カラ ファーマシューティカルズ インコーポレイテッド |
治療用化合物およびその使用
|
US9688688B2
(en)
|
2013-02-20 |
2017-06-27 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of 4-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxyquinazolin-7-yl)oxy)-1-(2-oxa-7-azaspiro[3.5]nonan-7-yl)butan-1-one and uses thereof
|
BR112015020572B1
(pt)
*
|
2013-02-28 |
2022-02-22 |
Sun Chemical Corporation |
Processo contínuo para transformar sólido moído em dispersão líquida e aparelho
|
WO2014210543A1
(en)
|
2013-06-28 |
2014-12-31 |
Rexahn Pharmaceuticals, Inc. |
Nanoparticulate compositions and formulations of piperazine compounds
|
US9458169B2
(en)
|
2013-11-01 |
2016-10-04 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
US9890173B2
(en)
|
2013-11-01 |
2018-02-13 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
WO2015071841A1
(en)
|
2013-11-12 |
2015-05-21 |
Druggability Technologies Holdings Limited |
Complexes of dabigatran and its derivatives, process for the preparation thereof and pharmaceutical compositions containing them
|
HU231309B1
(hu)
|
2014-02-25 |
2022-11-28 |
Darholding Kft. |
Nanostrukturált Indomethacint, gyógyszerészetileg elfogadott sóit és kokristályait tartalmazó készítmény és eljárás előállításukra
|
US20150343453A1
(en)
*
|
2014-05-28 |
2015-12-03 |
NanoCentrix L.L.C. |
Fluid energy media mill system and method
|
SI3182958T2
(sl)
|
2014-08-18 |
2022-07-29 |
Alkermes Pharma Ireland Limited |
Sestavki aripiprazol predzdravila
|
US10016415B2
(en)
|
2014-08-18 |
2018-07-10 |
Alkermes Pharma Ireland Limited |
Aripiprazole prodrug compositions
|
US10166197B2
(en)
|
2015-02-13 |
2019-01-01 |
St. John's University |
Sugar ester nanoparticle stabilizers
|
CA3127926A1
(en)
|
2015-04-21 |
2016-10-27 |
Sunovion Pharmaceuticals Inc. |
Methods of treating parkinson's disease by administration of apomorphine to an oral mucosa
|
EP3288957A4
(de)
|
2015-05-01 |
2019-01-23 |
Cocrystal Pharma, Inc. |
Nukleosidanaloga zur behandlung von viren der flaviviidae-familie und krebs
|
EP3310786B1
(de)
|
2015-06-16 |
2021-03-03 |
Nanophagix LLC |
Chemisches konjugat für wirkstofffreisetzung und bildgebung, formulierungen und verfahren zur verwendung davon
|
EA036155B1
(ru)
|
2015-10-16 |
2020-10-06 |
Маринус Фармасьютикалс, Инк. |
Инъекционные составы нейростероида, содержащие наночастицы
|
CA3014788A1
(en)
|
2016-02-17 |
2017-08-24 |
Alkermes Pharma Ireland Limited |
Compositions of multiple aripiprazole prodrugs
|
BR112019002538A2
(pt)
|
2016-08-11 |
2019-05-21 |
Ovid Therapeutics Inc. |
uso de uma composição farmacêutica compreendendo um modulador alostérico, uso de uma composição farmacêutica compreendendo garboxadol ou um sal farmaceuticamente aceitável do mesmo, e composição farmacêutica para a administração parenteral
|
AU2017324251A1
(en)
|
2016-09-08 |
2019-03-21 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
WO2018048747A1
(en)
|
2016-09-08 |
2018-03-15 |
Kala Pharmaceuticals, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
AU2017324716B2
(en)
|
2016-09-08 |
2020-08-13 |
KALA BIO, Inc. |
Crystalline forms of therapeutic compounds and uses thereof
|
US10391105B2
(en)
|
2016-09-09 |
2019-08-27 |
Marinus Pharmaceuticals Inc. |
Methods of treating certain depressive disorders and delirium tremens
|
PL3513809T3
(pl)
|
2016-09-13 |
2022-07-04 |
Kyowa Kirin Co., Ltd. |
Kompozycja lecznicza zawierająca tiwozanib
|
US11266662B2
(en)
|
2018-12-07 |
2022-03-08 |
Marinus Pharmaceuticals, Inc. |
Ganaxolone for use in prophylaxis and treatment of postpartum depression
|
CA3145923A1
(en)
|
2019-08-05 |
2021-02-11 |
David Czekai |
Ganaxolone for use in treatment of status epilepticus
|
MX2022006014A
(es)
|
2019-12-06 |
2022-06-22 |
Marinus Pharmaceuticals Inc |
Ganaxolona para uso en el tratamiento del complejo de esclerosis tuberosa.
|
EP3928772A1
(de)
|
2020-06-26 |
2021-12-29 |
Algiax Pharmaceuticals GmbH |
Nanopartikuläre zusammensetzung
|
CN112427096B
(zh)
*
|
2020-10-19 |
2022-01-28 |
上海旭军机械有限公司 |
一种纳米材料的研磨设备
|